Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

By L. Walker, S. Phogat, P. Chan-Hui, D. Wagner, P. Phung, J. L. Goss, T. Wrin, M. Simek, S. Fling, J. Mitcham and 11 more. Science, 2009

1,821 citations recorded by the source corpus.

Anti-HIV Antibodies One of the top priorities for an HIV vaccine is the ability to elicit a broadly neutralizing antibody response, which should provide the best protection against infection. In the 25 years since the discovery of HIV, very few broadly neutralizing antibodies have been identified, and those that do exist were discovered nearly two decades ago. Using a high-throughput culture system, Walker et al. (p. 285; published online 3 September) now identify two additional broadly neutralizing antibodies isolated from a clade A HIV-infected African donor. These antibodies exhibit great potency and, in contrast to other known broadly neutralizing antibodies, are able to neutralize a wide range of viruses from many different clades. The antibodies recognize a motif in the trimerized viral envelope protein that is found in conserved regions of the variable loops of the gp120 subunit. Identification of this motif provides an intriguing new target for vaccine development. High-throughput screening has revealed two new broadly neutralizing antibodies from a clade A–infected donor in Africa. Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1–infected individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we have examined neutralization breadth in the sera of about 1800 HIV-1–infected individuals, primarily infected with non–clade B viruses, and have selected donors for monoclonal antibody (mAb) generation. We then used a high-throughput neutralization screen of antibody-containing culture supernatants from about 30,000 activated memory B cells from a clade A–infected African donor to isolate two potent mAbs that target a broadly neutralizing epitope. This epitope is preferentially expressed on trimeric Envelope protein and spans conserved regions of variable loops of the gp120 subunit. The results provide a framework for the design of new vaccine candidates for the elicitation of bNAb responses.

Subfields: Hepatology, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/ae50667ff41584afd5c16dcbf8e89c9b00cf6e04

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

  1. Rafi Ahmed

In Infectious Diseases

  1. Rafi Ahmed

In Virology

  1. F. Sallusto
  2. Rafi Ahmed
  3. K. Araki
  4. A. Lanzavecchia

Citations in the corpus